Skip to main content
Download PDF

Retraction Note: Down-regulation of miR-133a and miR-539 are associated with unfavorable prognosis in patients suffering from osteosarcoma

Cancer Cell International volume 16, Article number: 84 (2016) Cite this article

The Original Article was published on 17 September 2015

Retraction to: Cancer Cell Int (2015) 15:86 DOI 10.1186/s12935-015-0237-6

The Editors-in-Chief and Publisher have retracted this article [1] because the scientific integrity of the content cannot be guaranteed. An investigation by the Publisher found it to be one of a group of articles we have identified as showing evidence suggestive of attempts to subvert the peer review and publication system to inappropriately obtain or allocate authorship. This article showed evidence of plagiarism (most notably from the articles cited [2, 3]) and authorship manipulation.

References

  1. Mirghasemi A, Taheriazam A, Karbasy SH, Torkaman A, Shakeri M, Yahaghi E, Mokarizadeh A. Down-regulation of miR-133a and miR-539 are associated with unfavorable prognosis in patients suffering from osteosarcoma. Cancer Cell Int. 2015;15:86. doi:10.1186/s12935-015-0237-6.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Ji F, Zhang H, Wang Y, Li M, Xu W, Kang Y, Wang Z, Wang Z, Cheng P, Tong D, Li C, Tang H. MicroRNA-133a, downregulated in osteosarcoma, suppresses proliferation and promotes apoptosis by targeting Bcl-xL and Mcl-1. Bone. 2013;56(1):220–6.

    Article  CAS  PubMed  Google Scholar 

  3. Bassampour SA, Abdi R, Bahador R, Shakeri M, Torkaman A, Yahaghi E, Taheriazam A. Downregulation of miR-133b/miR-503 acts as efficient prognostic and diagnostic factors in patients with osteosarcoma and these predictor biomarkers are correlated with overall survival. Tumor Biol. 2015. doi:10.1007/s13277-015-3918-9 (epub ahead of print).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Orthopedics, Qom University of Medical Sciences, Qom, Iran

    Alireza Mirghasemi

  2. Department of Orthopedics Surgery, Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran

    Afshin Taheriazam

  3. Department of Anesthesiology, Birjand University of Medical Sciences, Birjand, Iran

    Seyyed Hasan Karbasy

  4. Department of Orthopedics, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran

    Ali Torkaman

  5. Department of Orthopaedic and Trauma Surgery, Birjand University of Medical Sciences, Birjand, Iran

    Mohammadreza Shakeri

  6. Department of Molecular Biology, Baqiyatallah University of Medical Sciences, Tehran, Iran

    Emad Yahaghi

  7. Cellular & Molecular Research Center, Kurdistan University of Medical Sciences, Sanandaj, Iran

    Aram Mokarizadeh

Authors
  1. Alireza Mirghasemi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Afshin Taheriazam
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Seyyed Hasan Karbasy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ali Torkaman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mohammadreza Shakeri
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Emad Yahaghi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Aram Mokarizadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Aram Mokarizadeh.

Additional information

The online version of the original article can be found under doi:10.1186/s12935-015-0237-6.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mirghasemi, A., Taheriazam, A., Karbasy, S.H. et al. Retraction Note: Down-regulation of miR-133a and miR-539 are associated with unfavorable prognosis in patients suffering from osteosarcoma. Cancer Cell Int 16, 84 (2016). https://doi.org/10.1186/s12935-016-0359-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12935-016-0359-5

Cancer Cell International

ISSN: 1475-2867

Contact us